YOLFTbeta
65

Concord Medical Co., Ltd.

6518 · TWO · Healthcare / Medical Instruments & Supplies

29.60TWD-0.40 (-1.33%)

Price History

Full chart

Market Stats

Previous Close30.00
Open29.60
Day Range29.60 – 29.60
52-Week Range24.12 – 53.60
Volume2.00K
Market Cap1.05B
P/E (TTM)12.70
Forward P/E0.00
EPS2.56
Dividend Yield4.62%
Beta0.30
50-Day Avg31.52
200-Day Avg29.68

About

Concord Medical Co., Ltd. provides hospital management support services primarily in Taiwan. The company offers medical management services that include medical training and nursing staffing and assisting on medical management; and procurement services for instruments and equipment, drugs, medical materials and consumables, testing equipment, and reagents and consumables, as well as develops its own brand for medical aesthetic skincare products, health foods, and topical Chinese medicine products. It is also involved in the medical equipment planning and sales; and medical equipment leasing activities. The company was founded in 2009 and is headquartered in New Taipei City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOJianling Hon
  • HeadquartersNo. 266, Wenhua Road, New Taipei City, Taiwan, 22041, Taiwan
  • Websitehttps://www.concordmed.com.tw

Leadership

  • Jianling HonGM & Director
  • Fuan LiuCFO & Director
  • Weiting LuAccounting Supervisor
  • Mr. Yangren LaiDeputy General Manager

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue763.77M809.70M738.99M889.21M833.20M889.85M964.35M
Growth (%)-+6.01%-8.73%+20.33%-6.30%+6.80%+8.37%
Cost of Revenue687.63M745.30M670.50M780.11M731.05M780.23M830.39M
Gross Profit76.14M64.41M68.49M109.10M102.15M109.62M133.96M
Gross Margin9.97%7.95%9.27%12.27%12.26%12.32%13.89%
Operating Expense34.18M36.34M31.02M44.31M47.23M47.79M61.16M
Operating Income41.96M28.06M37.47M64.78M54.91M61.83M72.81M
Operating Margin5.49%3.47%5.07%7.29%6.59%6.95%7.55%
EBITDA123.89M135.07M144.16M143.47M137.47M152.22M171.69M
EBITDA Margin16.22%16.68%19.51%16.13%16.50%17.11%17.80%
Net Income31.38M19.77M34.40M50.66M42.74M49.57M67.36M
Net Income Margin4.11%2.44%4.65%5.70%5.13%5.57%6.99%
Interest Expense7.47M6.30M4.79M3.51M3.52M3.55M3.89M
Interest Expense % of Total Revenue0.98%0.78%0.65%0.40%0.42%0.40%0.40%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.11B1.09B1.08B1.18B1.15B1.16B1.22B
Total Liabilities603.50M575.42M445.25M464.06M470.71M466.53M466.45M
Total Equity503.43M513.23M637.63M671.62M681.03M697.26M727.96M
Cash51.91M59.42M198.80M246.91M111.26M109.75M125.18M
Total Debt357.91M344.84M216.81M197.82M216.04M210.86M-
Net Debt306.00M285.42M18.02M-49.09M104.78M101.11M-

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow131.06M84.06M137.42M154.56M113.23M148.83M157.24M
Investing Cash Flow-31.05M-54.86M33.17M-110.31M-188.08M-92.33M-
Financing Cash Flow-60.15M-46.52M-31.22M3.87M-60.80M-58.02M-
Capital Expenditure69.93M93.98M21.95M38.08M89.69M76.36M35.29M
Free Cash Flow61.13M-9.92M115.48M116.48M23.54M72.47M121.95M
Dividends Paid10.00M10.00M10.00M16.67M33.33M33.33M36.67M
FCF to OCF46.64%-11.80%84.03%75.37%20.79%48.69%77.56%
Dividend Paid to FCF16.36%-100.83%8.66%14.31%141.60%45.99%30.07%

Key Statistics & Ratios

Market Cap1.05B
Enterprise Value1.05B
Trailing P/E12.70
Forward P/E0.00
Price / Sales1.04
Price / Book1.50
EPS2.56
Book Value21.76
Revenue (TTM)1.04B
Gross Profit (TTM)147.33M
EBITDA120.35M
Profit Margin8.26%
Operating Margin6.10%
Return on Equity12.00%
Return on Assets3.58%
Shares Outstanding33.33M
Shares Float6.34M
Beta0.30
Dividend Yield4.62%
Dividend Rate1.50
Payout Ratio58.53%

Dividends

20261×
1.50Apr 10, 2026
20251×
1.10Apr 10, 2025
20241×
1.00Apr 2, 2024
20231×
1.00Mar 30, 2023
20221×
0.50Jun 28, 2022
20211×
0.40Aug 24, 2021
20201×
0.40Jul 10, 2020
20191×
0.40Jul 12, 2019
20171×
0.40Jul 12, 2017
20161×
0.40Sep 5, 2016